Julie Horgen Evensen

Dr. Julie Horgen Evensen


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2021 in BMC Psychology
Verified
Journal Article
Open access
PDF file
Jan Røssberg,Jan Røssberg,
Jan Røssberg,
JEJulie Horgen Evensen
Julie Horgen Evensen
TDToril Dammen
Toril Dammen
TWTheresa Wilberg
Theresa Wilberg
OKO. Klungsøyr
O. Klungsøyr
Randi UlbergRandi Ulberg
Randi Ulberg
Major depressive disorder (MDD) is a prevalent psychiatric condition associated with significant disability, mortality and economic burden. Cognitive behavioral therapy (CBT) and psychodynamic psychotherapy (PDT) are found to be equally effective for patients with depression. However, many patients do not respond sufficiently to either treatment. To offer individualized treatment, we need to know if some patients benefit more from one of the two therapies. At present little is known about what patient characteristics (moderators) may be associated with differential outcomes of CBT and PDT, and through what therapeutic processes and mechanisms (mediators) improvements occur in each therapy mode. Presently only theoretical assumptions, sparsely supported by research findings, describe what potentially moderates and mediates the treatment effects of CBT and PDT. The overall aim of this study is to examine theoretically derived putative moderators and mediators in CBT and PDT and strengthen the evidence base about for whom and how these treatments works in a representative sample of patients with MDD. One hundred patients with a diagnosis of MDD will be randomized to either CBT or PDT. Patients will be treated over 28 weeks with either CBT (one weekly session over 16 weeks and three monthly booster sessions) or PDT (one weekly session over 28 weeks). The patients will be evaluated at baseline, during the course of therapy, at the end of therapy, and at follow-up investigations 1 and 3 years post treatment. A large range of patient and observer rated questionnaires (specific preselected putative moderators and mediators) are included. The clinical outcome of this study may better guide clinicians when deciding what kind of treatment any individual patient should be offered. Moreover, the study aims to further our knowledge of what mechanisms lead to symptom improvement and increased psychosocial functioning. ClinicalTrials.gov Identifier: NCT03022071.

28 May 2024 in Frontiers in Psychology
Verified
Journal Article
Open access
PDF file
VVVeronica Vaage-Kowalzik
Veronica Vaage-Kowalzik
JEJeanette Engeset
Jeanette Engeset
MJMarianne Jakobsen
Marianne Jakobsen
WAWenche Andreassen
Wenche Andreassen
JEJulie Horgen Evensen
Julie Horgen Evensen
Background: Intensive inpatient treatment programs have shown robust results in the treatment of post-traumatic stress disorder (PTSD). How patients experience this treatment program and what changes they experience as a result of the treatment have, however, only scarcely been explored through qualitative studies.Objective: This study aimed to explore the lived experience of participants in an intensive inpatient trauma treatment program. Our research questions were as follows: how do patients experience intensive trauma-focused treatment? How do they experience possible changes related to participating in the treatment program?Methods: Six patients diagnosed with PTSD with significant comorbidities, who recently participated in an intensive 2-week (4 + 4 days) inpatient trauma treatment program with prolonged exposure (PE), eye movement desensitization and reprocessing (EMDR), and therapist rotation (TR), were interviewed with a semi-structured qualitative interview. Transcripts were analyzed using a thematic analysis approach.Results: Our analysis resulted in five main themes: (1) the need to feel safe; (2) the benefits of many and different therapeutic encounters; (3) variable experience with elements of treatment; (4) intensity; and (5) experienced change. Our results suggest that feeling safe within the framework of the treatment program facilitated the treatment process. Many and different therapeutic encounters, both through TR and with ward staff, contributed to experienced change. All participants described the intensity as facilitative to trauma processing. However, most participants also describe often feeling too overwhelmed to benefit from all elements of the treatment program.Conclusions: Our findings suggest that participants experience the overall treatment program as beneficial and contributing to experienced change. Participants described the intensity of the program as exhausting, but necessary. Most did, however, report at times of being too overwhelmed to benefit from elements of the program. Consequently, our results prompt us to question the optimal level of intensity.Trial registration: ClinicalTrials.gov identifier: NCT05342480. Date of registration: 2022-04-22.

AMAnders Malkomsen
Anders Malkomsen
Jan Røssberg,Jan Røssberg,
Jan Røssberg,
TDToril Dammen
Toril Dammen
TWTheresa Wilberg
Theresa Wilberg
ALAndré Løvgren
André Løvgren
JEJulie Horgen Evensen
Julie Horgen Evensen
Background: There is a substantial lack of qualitative research concerning individual cognitive behavioral therapy (CBT) for patients with major depressive disorder (MDD). In the present study, we wanted to explore how patients suffering from MDD experience improvement in CBT. Method: Patients with MDD (N = 10) were interviewed at therapy termination with semi-structured qualitative interviews. The transcripts were analyzed using a thematic analysis approach. Results: We identified three elements that were relevant to the process of improvement for all patients: the therapeutic relationship, the therapeutic interventions and increased insight. There is a dynamic interrelationship and synergy between these elements that may explain why patients considered the same elements as helpful, but often in different ways and at different stages of therapy. Conclusions: Highlighting the synergies and interrelationship between the elements that patients experience as helpful, may help therapists to learn from and utilize these experiences. This is a reminder of the importance of always being attentive to the individual processes of patients.

9 September 2026 in Frontiers in Psychology
Verified
Journal Article
Open access
PDF file
JEJulie Horgen Evensen
Julie Horgen Evensen
JEJeanette Engeset
Jeanette Engeset
MJMarianne Jakobsen
Marianne Jakobsen
AMAnders Malkomsen
Anders Malkomsen
VVVeronica Vaage-Kowalzik
Veronica Vaage-Kowalzik
Background: Intensive trauma-focused treatment (ITFT) has demonstrated robust results in treating post-traumatic stress disorder (PTSD) in specialized trauma centers. Whether this treatment is feasible in a non-specialized treatment facility has not been previously investigated. Objective: This pilot study aimed to examine if an ITFT program is feasible in a non-trauma-specialized public treatment facility, where many therapists had limited experience with trauma-focused treatment. Methods: Eighteen female patients diagnosed with PTSD or Complex PTSD (CPTSD), with multiple traumas and comorbidity, participated in an intensive 2-week (4 + 4 days) inpatient trauma treatment program that included Prolonged Exposure, Eye Movement Desensitization and Reprocessing, group psychoeducation, and physical activity, and that also used therapist rotation. The patients were assessed using a battery of validated self-report questionnaires and interviews before and after the intervention, and at 2 and 6 months post-treatment. Therapists' and ward staff's readiness to provide TFT was assessed with a questionnaire after participating in the program. Results: All participants completed treatment. Individual session attendance was very high, and no significant adverse effects were reported. The reduction in PTSD symptoms was considerable and sustained, with 83% of the sample showing clinically reliable change at the 6-month follow-up. Half of patients with a CPTSD diagnosis and all patients with a PTSD diagnosis lost their diagnosis. Trauma-related negative cognitions also showed a statistically significant reduction from baseline to the 6-month follow-up. Treatment satisfaction was high, including measures of the individual treatment components, and therapist rotation. Both therapists and ward staff reported increased readiness to start TFT after participating in the project. Conclusions: This feasibility study indicates that intensive trauma-focused treatment for PTSD and CPTSD is acceptable and associated with symptom improvement in a public treatment facility. Trial registration: ClinicalTrials.gov identifier: NCT05342480. Date of registration: 2022-04-22.